Using Hair Loss Treatments? Here's Why You May Need to Wait Six Months

Most people judge a hair loss treatment the way they judge a skincare product: if nothing is visibly different in a month or two, it is not working. For hair, that logic is wrong in a way that costs real results.

The problem is not the treatment. It is the hair growth cycle, which operates on a timeline no product can override.

Each hair follicle cycles through three phases independently of every other follicle on your scalp. Anagen is the active growth phase, lasting anywhere from two to six years. Catagen is a short transitional phase of a few weeks. Telogen is the resting phase, lasting roughly three months, after which the hair sheds and the follicle restarts. At any given time, roughly 85 to 90 percent of your scalp hairs are in anagen, and the rest are in telogen.

When a treatment works, it does so by extending anagen, shortening telogen, or stimulating a follicle that has miniaturised back toward normal function. None of those changes are visible at the surface for months, because the hair that grows from a newly stimulated follicle still has to physically travel up through the scalp. Hair grows at roughly 1 to 1.5 centimetres per month. A follicle that responds to treatment in week four produces hair you will not see at the surface until week eight or ten, and will not notice as density until much later.

The first six weeks of many treatments, particularly minoxidil, the most widely used topical option, can produce the opposite of what someone hopes to see. Minoxidil works partly by pushing follicles in late telogen into shedding so they can restart in anagen sooner. This produces a temporary increase in shedding, sometimes called a duff shed, that can last four to eight weeks. It looks like the treatment is causing hair loss. It is not. It is the cycle resetting.

This is one of the most documented reasons people stop effective treatments early. They see more hair on the pillow, panic, and discontinue. The follicles that were about to re-enter anagen never get the chance.

Platelet-rich plasma therapy, used for androgenetic hair loss and some cases of alopecia areata, has a different early timeline. The growth factors delivered during a session act on follicle cells over weeks, and the cellular response precedes any visible change by a significant margin. Most practitioners who use PRP for hair loss consider six months the minimum point at which outcome can be fairly assessed, and a full course typically involves multiple sessions spaced weeks apart.

The six-month evaluation point is not arbitrary. It reflects the minimum time needed for a follicle that responds to treatment to produce a hair long enough to contribute meaningfully to visible density. Clinical trials for hair loss treatments use this window because anything shorter produces data that does not reflect real outcomes.

For androgenetic hair loss, the most common type in both men and women, driven by the conversion of testosterone to dihydrotestosterone and its effect on follicle miniaturisation, the six-month mark is where meaningful density change becomes photographically measurable. Some people see earlier signs; many do not. The absence of visible change at week ten is not evidence that the treatment has failed.

It is also worth noting that six months is a minimum, not a finish line. Many treatments require continued use to maintain the follicle environment that allows regrowth. Stopping after six months because results have appeared is as premature as stopping at six weeks because they have not.

This timeline applies to treatments that address the underlying cause of a given type of hair loss. It does not apply universally, because not all hair loss has the same cause.

Telogen effluvium, a diffuse shed triggered by physical or psychological stress, illness, rapid weight loss, or nutritional deficiency, often resolves on its own once the trigger is removed, and treatments aimed at androgenetic loss do nothing to accelerate that. Traction hair loss from tight hairstyles involves follicle damage that may or may not be reversible depending on how long the traction has been applied. Scalp inflammation from seborrhoeic dermatitis or psoriasis requires the inflammation to be treated first; applying a growth-stimulating treatment to an inflamed scalp addresses the wrong problem.

A dermatologist can distinguish these causes through examination and, where needed, a scalp biopsy or blood panel. Self-diagnosis based on pattern alone is unreliable, and treating the wrong cause for six months wastes exactly the time this article is asking you to give the right treatment.

Because visible density change is a lagging indicator, tracking it daily is counterproductive and often misleading. Lighting, scalp moisture, how hair is parted, and how recently it was washed all affect how much hair appears to be present. A photograph taken in the same light, from the same angle, on the same day each month is a more reliable record than daily inspection.

Some people find it useful to track shedding counts during the early weeks, not to measure loss, but to identify when the initial shed tapers off, which is often the first sign that the cycle is stabilising. A trichologist or dermatologist can also use dermoscopy to assess follicle health at the scalp level before surface density changes are visible, which gives a more accurate picture of whether a treatment is having any biological effect.

The six-month rule exists because hair biology is slow, not because the treatments are weak. Giving a treatment the time it actually needs is not patience for its own sake, it is the only way to find out whether it works for you.

Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!